As of Nov 25
| +0.16 / +2.26%|
The 5 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 20.00, with a high estimate of 31.00 and a low estimate of 17.00. The median estimate represents a +176.63% increase from the last price of 7.23.
The current consensus among 5 polled investment analysts is to Buy stock in Inovio Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.